Novartis to expand oncology portfolio with acquisition of Mariana Oncology
Novartis has announced a significant move in the oncology sector with its agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts. The transaction, valued at approximately $1.75 billion, including milestone payments, underscores Novartis’s commitment to advancing its capabilities in radioligand therapies (RLTs), a promising area of cancer treatment. Details of the […]